Anthropic moves drug experiments from simulation to a physical lab
Anthropic is building a Bay Area biology lab where Claude directs robots through wet-lab experiments; still under construction, worth tracking for actual output.
Original event 2026-09-18
Anthropic is building its own biology lab in the San Francisco area, where Claude will guide robots through drug experiments with minimal human involvement. According to The Decoder, citing Reuters on September 18, the company has already shipped two tools for this: Claude Science, a research workspace, and the Model Hardware Standard for controlling lab equipment.
The lab extends a life-sciences push from earlier this year: in April, Anthropic acquired Coefficient Bio for about $400 million and added Novartis CEO Vas Narasimhan to its board. Division head Eric Kauderer-Abrams sees the biggest opportunity in diseases long considered "undruggable."
The lab is still being set up and has produced no results; Anthropic says it will not run its own clinical trials for now, and human oversight for safety remains required.